Адъювантная андрогенная блокада после дистанционной лучевой терапии при раке предстательной железы -отдаленные результаты III фазы исследования RTOG 85-31
| Autor: | Pilepich, Miljenko, Winter, Kathryn, Lawton, Colleen, Krisch, Robert, Wolkov, Harvey, Movsas, Benjamin, Hug, Eugen, Asbell, Sucha, Grignon, David |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2007 |
| Zdroj: | Онкоурология. |
| ISSN: | 1996-1812 1726-9776 |
| Popis: | The RTOG 85-31 study has indicated that adjuvant hormonotherapy is particularly effective in prostate cancer (PC) patients with a high Glisson score. Long-term adjuvant hormonotherapy is not warranted in patients with a total Glisson score of 2-6. Exception is patients with disseminated locally advanced tumors, in whom neoadjuvant androgenic suppression (RTOG 86-10 protocol) considerably improves the results of treatment. Long-term adjuvant hormonotherapy may be the method of choice in treating PC patients with a poor prognosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
